Search Results 251-260 of 17950 for SARS-CoV-2
"During a pandemic with a highly transmissible respiratory pathogen like SARS-CoV-2 (the virus that causes COVID-19), it is highly advisable to reduce or ...
This may require that we examine all three cohorts listed in the Subject Information section. The third aim is to measure SARS-CoV-2 anti-spike and anti- ...
... COVID-19. For more information. Chumsri S, et al. Humoral responses after SARS-CoV-2 mRNA vaccination and breakthrough infection in cancer patients. Mayo ...
The projections take into account new variants of the SARS-CoV-2 virus as well as current public health measures and masking standards. The predicted ICU ...
... SARS-CoV-2 COVID-19 Research Task Force, a group charged with oversight of all COVID-19-related research activities. This multidisciplinary group aligns ...
The third aim is to measure SARS-CoV-2 anti-spike and anti-nucleocapsid antibodies to distinguish patients that have not been exposed to SARS-CoV-2 to those ...
"We are moving toward SARS-CoV-2 being a pandemic virus," says Dr. Gregory Poland, director of Mayo Clinic's Vaccine Research Group. The virus has been named[..
Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among ...
Until a vaccine is developed, public health measures are the best defense against SARS-CoV-2, the virus that causes COVID-19. These measures include masking ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!